Day One Biopharmaceuticals Inc (DAWN)
US$ 7.22-6.36%
Price Chart
Key Statistics
Market Cap
$ 649.73M
P/E Ratio
0.00
Revenue (TTM)
$ 161.92M
Volume
920.37K
52W High
$ 16.76
52W Low
$ 6.08
Dividend Yield
0.00%
Beta
-1.30
Technicals
50-Day MA
6.876
200-Day MA
11.0695
52 Week High
16.76
52 Week Low
6.08
About DAWN
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.
Employees
181
Headquarters
Brisbane, CA
CEO
Dr. Jeremy Bender M.B.A., Ph.D.
Latest News
Former Golden Dawn MP found guilty of treason but will not be punished - eKathimerini.com
16 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg